Enzymology in Drug Discovery
Enzymes are the macromolecular and micromolecular proteins in the drug design that act as drug targets for the diseases in the process of discovery of drugs as well as its development. Drug target is a nucleic acid or a protein whose activity can be modified by a drug itself. The drug target should be effective in the disease by relevant in vitro or in vivo models and analysis.
- Drug designing using enzymes
- Drug development using enzymes
- Drug modelling
- Drug targeting
Related Conference of Enzymology in Drug Discovery
Enzymology in Drug Discovery Conference Speakers
Recommended Sessions
- Clinical Enzymology
- Computational Enzymology
- Enzyme Kinetics
- Enzyme Nanotechnology
- Enzyme Toxicology
- Enzymology & Biochemistry
- Enzymology & Proteomics
- Enzymology & Thermodynamics
- Enzymology in Drug Discovery
- Enzymology in Food Processing & Technology
- Genomics
- Industrial Applications of Enzymology
- Lipid and Lipoprotein Metabolism
- Molecular Enzymology
- Molecular Genetics
- Soil Enzymology
- Structural Enzymology
Related Journals
Are you interested in
- Biochemistry - Glycobiology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)